Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors
The Journal of Clinical and Aesthetic Dermatology
More Info
The Journal of Clinical and Aesthetic Dermatology
Lisa Swanson, MD: Things to Consider When Starting Patients on JAK Inhibitors
Jun 23, 2022
JCAD

Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist with Ada West Dermatology in Boise, Idaho, reviews the role that Janus kinases (JAKs) play in the inflammatory process and the benefits of inhibiting this enzyme when treating patients with atopic dermatitis. She also elaborates upon her experiences using the newly approved JAK inhibitors in her own patients. Dr. Swanson then outlines things to consider before starting patients on JAK inhibitors.